Start your patients on the #1 prescribed prostacyclin treatment.1*
Learn more
FOR US HEALTHCARE PROFESSIONALS ONLY
For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
PAH (WHO GROUP 1)
Discover TYVASO DPI’s innovative device design for efficient drug delivery to the distal airways, with just one breath.
Learn more about how to use TYVASO DPI for the treatment of PAH.
Learn how to prepare and use the TYVASO nebulizer.
See the benefits of delivering medications directly to the lungs.
Learn more about important factors that impact optimal delivery of inhaled therapies to the site of disease.
See how PAH affects the blood vessels, heart, and lungs.